Gene · 189
Papers3,768
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
661 to 680 of 3,768
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Autoinhibition of the GEF activity of cytoskeletal regulatory protein Trio is disrupted in neurodevelopmental disorder-related genetic variants. | J Biol Chem | 2022 | 35963430 | PubTator, text mining | PubMed |
| Comprehensive Health Evaluation Model of Art Psychotherapy Using Genetic Algorithm. | Comput Intell Neurosci | 2022 | 35958743 | PubTator, text mining | PubMed |
| Design and selection of peptides to block the SARS-CoV-2 receptor binding domain by molecular docking. | Beilstein J Nanotechnol | 2022 | 35957673 | PubTator, text mining | PubMed |
| Down-regulated m6A reader FTO destabilizes PHF1 that triggers enhanced stemness capacity and tumor progression in lung adenocarcinoma. | Cell Death Discov | 2022 | 35945194 | PubTator, text mining | PubMed |
| Neural activity during solo and choral reading: A functional magnetic resonance imaging study of overt continuous speech production in adults who stutter. | Front Hum Neurosci | 2022 | 35937674 | PubTator, text mining | PubMed |
| Clinical Eosinophil-Associated Genes can Serve as a Reliable Predictor of Bladder Urothelial Cancer. | Front Mol Biosci | 2022 | 35936781 | PubTator, text mining | PubMed |
| Immune Evasion and Drug Resistance Mediated by USP22 in Cancer: Novel Targets and Mechanisms. | Front Immunol | 2022 | 35935969 | PubTator, text mining | PubMed |
| Metabonomic analysis of abnormal sphingolipid metabolism in rheumatoid arthritis synovial fibroblasts in hypoxia microenvironment and intervention of geniposide. | Front Pharmacol | 2022 | 35935818 | PubTator, text mining | PubMed |
| Identifying signatures of natural selection in Indian populations. | PLoS One | 2022 | 35925921 | PubTator, text mining | PubMed |
| Integrative Analyses Identify Potential Key Genes and Calcium-Signaling Pathway in Familial Atrioventricular Nodal Reentrant Tachycardia Using Whole-Exome Sequencing. | Front Cardiovasc Med | 2022 | 35924220 | PubTator, text mining | PubMed |
| Two independent modes of kidney stone suppression achieved by AIM/CD5L and KIM-1. | Commun Biol | 2022 | 35922481 | PubTator, text mining | PubMed |
| A retrospective analysis of endocrine disease in sphingosine-1-phosphate lyase insufficiency: case series and literature review. | Endocr Connect | 2022 | 35904228 | PubTator, text mining | PubMed |
| The SPTLC1 p.S331 mutation bridges sensory neuropathy and motor neuron disease and has implications for treatment. | Neuropathol Appl Neurobiol | 2022 | 35904184 | PubTator, text mining | PubMed |
| SPTLC1 variants associated with ALS produce distinct sphingolipid signatures through impaired interaction with ORMDL proteins. | J Clin Invest | 2022 | 35900868 | PubTator, text mining | PubMed |
| Ciliogenesis requires sphingolipid-dependent membrane and axoneme interaction. | Proc Natl Acad Sci U S A | 2022 | 35895683 | PubTator, text mining | PubMed |
| Loss of tolerance to multiple environmental stresses due to limitation of structural diversity of complex sphingolipids. | Mol Biol Cell | 2022 | 35895092 | PubTator, text mining | PubMed |
| Comparison of Tofogliflozin and Glimepiride Effects on Nonalcoholic Fatty Liver Disease in Participants With Type 2 Diabetes: A Randomized, 48-Week, Open-Label, Active-Controlled Trial. | Diabetes Care | 2022 | 35894933 | PubTator, text mining | PubMed |
| PNPLA1-Mediated Acylceramide Biosynthesis and Autosomal Recessive Congenital Ichthyosis. | Metabolites | 2022 | 35893253 | PubTator, text mining | PubMed |
| Differential Protein Expression among Two Different Ovine ARDS Phenotypes-A Preclinical Randomized Study. | Metabolites | 2022 | 35888779 | PubTator, text mining | PubMed |
| Ceramide and Sphingosine-1-Phosphate in Neurodegenerative Disorders and Their Potential Involvement in Therapy. | Int J Mol Sci | 2022 | 35887154 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/189/papers?page=34